1
Country: Israel | Funding: $185M
Healthy.io de Dip.io, a home-based urinalysis kit that turns a smartphone into a clinical-grade diagnostic device. It’s the first smartphone-based urine test to secure clearance as a Class 2 device.
Healthy.io de Dip.io, a home-based urinalysis kit that turns a smartphone into a clinical-grade diagnostic device. It’s the first smartphone-based urine test to secure clearance as a Class 2 device.
2
Country: USA | Funding: $91M
Q Bio operates as a platform that provides a physical health picture of the users.
Q Bio operates as a platform that provides a physical health picture of the users.
3
Country: Israel | Funding: $83M
Nucleix is developing liquid biopsy technology for the early detection of cancer. Its first product - Bladder EpiCheck test is certified for the diagnosis of primary and recurrent bladder and upper urinary tract cancer. This in vitro diagnostic device detects DNA methylation patterns in urine associated with urothelial carcinoma. It is intended for use as non-invasive method for monitoring tumor recurrence in conjunction with standard diagnostic procedures. The test analyzes small, disease-specific changes in DNA methylation markers, enabling the detection of cancer. The test has demonstrated high sensitivity (91%) for high-grade tumors, which are important to detect because they are aggressive and, if not treated immediately, can progress to invasive cancer. The company is also developing Lung EpiCheck to detect lung cancer at an early stage in high-risk individuals using a simple blood test.
Nucleix is developing liquid biopsy technology for the early detection of cancer. Its first product - Bladder EpiCheck test is certified for the diagnosis of primary and recurrent bladder and upper urinary tract cancer. This in vitro diagnostic device detects DNA methylation patterns in urine associated with urothelial carcinoma. It is intended for use as non-invasive method for monitoring tumor recurrence in conjunction with standard diagnostic procedures. The test analyzes small, disease-specific changes in DNA methylation markers, enabling the detection of cancer. The test has demonstrated high sensitivity (91%) for high-grade tumors, which are important to detect because they are aggressive and, if not treated immediately, can progress to invasive cancer. The company is also developing Lung EpiCheck to detect lung cancer at an early stage in high-risk individuals using a simple blood test.
4
Country: Japan | Funding: $35.5M
Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology. The test can detect 7 types of cancer (pancreatic, colorectal, lung, stomach, esophagus breast, ovarian) from a simple urine draw.
Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology. The test can detect 7 types of cancer (pancreatic, colorectal, lung, stomach, esophagus breast, ovarian) from a simple urine draw.
5
Country: Hong Kong | Funding: $34.9M
Phase Scientific is developing urine-based diagnostics tests for early disease detection
Phase Scientific is developing urine-based diagnostics tests for early disease detection
6
Country: USA | Funding: $21.4M
Vivoo is a wellness assistant that provides custom nutrition advice to the users based on their urine sample analysis.
Vivoo is a wellness assistant that provides custom nutrition advice to the users based on their urine sample analysis.
7
Country: UK | Funding: $19.1M
TestCard is the innovative medtech behind the 'urine test-in-a-postcard' concept. Its accompanying mobile app provides an immediate result.
TestCard is the innovative medtech behind the 'urine test-in-a-postcard' concept. Its accompanying mobile app provides an immediate result.
8
Country: Israel | Funding: $10M
Olive Diagnostics has developed the world's only pure optic urine sensor that mounts to the toilet and performs urinalysis in real time every time a user uses the toilet.
Olive Diagnostics has developed the world's only pure optic urine sensor that mounts to the toilet and performs urinalysis in real time every time a user uses the toilet.
9
Country: Japan | Funding: $4.9M
Home health lab that provides personalized nutrition and lifestyle advice, through easy, accurate urine and saliva tests.
Home health lab that provides personalized nutrition and lifestyle advice, through easy, accurate urine and saliva tests.
10
Country: Croatia | Funding: €50K
Nocturiglow operates in the Health and Medical Care industry with its user-friendly urinal bottle.
Nocturiglow operates in the Health and Medical Care industry with its user-friendly urinal bottle.
11
Country: Japan
Symax analyzes urine by attaching it inside a toilet for analyzing health conditions. It enables early detection of lifestyle diseases such as diabetes and gout with 99% accuracy leveraging the original algorithm.
Symax analyzes urine by attaching it inside a toilet for analyzing health conditions. It enables early detection of lifestyle diseases such as diabetes and gout with 99% accuracy leveraging the original algorithm.
12
Country: South Africa
Sensible Health has developed the first and only integrated ‘sterile’ urine testing device in the market, which completes the ecosystem from a point of care testing to laboratory.
Sensible Health has developed the first and only integrated ‘sterile’ urine testing device in the market, which completes the ecosystem from a point of care testing to laboratory.
